Japan’s New Infertility Coverage To Drive The Market

ART Drugs Approved At Fast Pace

Japan's national health insurance scheme will reimburse infertility treatments from April 2022, in a bid to make the treatments more accessible to patients by effectively lowering the cost by 70%. The key strategic aim is to raise a low birth rate and the move is also set to substantially expand the market for such products for both domestic and foreign players.

newborn baby
reimbursement coverage a key measure to raising Japan birth rate • Source: Alamy

More from Japan

More from Asia